Clinical trial
SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults…
NCT00290264 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00290264 |
|---|---|
| Title | SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma |
| Official title | A Comparison of Symbicort Single Inhaler Therapy (Symbicort Turbohaler 160/4.5 μg, 1 Inhalation b.i.d. Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults - a 26-week, Randomised, Open-label, Parallel-group, Multi-centre Study (SALTO) |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Budesonide/formoterol |
| Enrollment | 1,000 |
| Start date | Dec 1, 2004 |
| Completion | Aug 1, 2006 |
| First posted | Feb 13, 2006 |
| Last update posted | Jan 24, 2011 |
| Countries | Belgium, Luxembourg |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: